Annual report
4503.TEDINET S100YBPK
Period2025-04-01 → 2026-03-31
Filed2026-06-16
StandardIFRS
ConsolidatedYes
Data checks21 of 21 passed
Key figures · 157
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.14T | 2025-04-01 → 2026-03-31 | Cons. | Revenue IFRS |
| Revenue | ¥1.91T | 2024-04-01 → 2025-03-31 | Cons. | Revenue IFRS |
| Revenue | ¥1.60T | 2023-04-01 → 2024-03-31v | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥1.52T | 2022-04-01 → 2023-03-31v | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥1.30T | 2021-04-01 → 2022-03-31v | Cons. | Revenue IFRS (5-year summary) |
| Operating income | ¥382.6bn | 2025-04-01 → 2026-03-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥41.0bn | 2024-04-01 → 2025-03-31 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥376.6bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥31.2bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥25.0bn | 2023-04-01 → 2024-03-31v | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥132.4bn | 2022-04-01 → 2023-03-31v | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥156.9bn | 2021-04-01 → 2022-03-31v | Cons. | Profit loss before tax IFRS (5-year summary) |
| Net income (owners) | ¥291.5bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥50.7bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥17.0bn | 2023-04-01 → 2024-03-31v | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥98.7bn | 2022-04-01 → 2023-03-31v | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥124.1bn | 2021-04-01 → 2022-03-31v | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income | ¥291.6bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss IFRS |
| Net income | ¥50.7bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss IFRS |
| Total assets | ¥3.57T | at 2026-03-31 | Cons. | Assets IFRS |
| Total assets | ¥3.34T | at 2025-03-31 | Cons. | Assets IFRS |
| Total assets | ¥3.57T | at 2024-03-31v | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥2.46T | at 2023-03-31v | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥2.33T | at 2022-03-31v | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥1.74T | at 2026-03-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥1.83T | at 2025-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥1.83T | at 2026-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.51T | at 2025-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.60T | at 2024-03-31v | Cons. | Equity IFRS |
| Equity (owners) | ¥1.83T | at 2026-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.51T | at 2025-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.60T | at 2024-03-31v | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥1.51T | at 2023-03-31v | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥1.46T | at 2022-03-31v | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥281.6bn | at 2026-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥188.4bn | at 2025-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥335.7bn | at 2024-03-31v | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥376.8bn | at 2023-03-31v | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Cash & equivalents | ¥316.0bn | at 2022-03-31v | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Operating cash flow | ¥560.2bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥194.5bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥172.5bn | 2023-04-01 → 2024-03-31v | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥327.8bn | 2022-04-01 → 2023-03-31v | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥257.4bn | 2021-04-01 → 2022-03-31v | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Investing cash flow | −¥66.7bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥89.4bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥845.8bn | 2023-04-01 → 2024-03-31v | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥84.5bn | 2022-04-01 → 2023-03-31v | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥62.4bn | 2021-04-01 → 2022-03-31v | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Financing cash flow | −¥404.8bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥261.4bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | ¥614.1bn | 2023-04-01 → 2024-03-31v | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥195.6bn | 2022-04-01 → 2023-03-31v | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥216.3bn | 2021-04-01 → 2022-03-31v | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| EPS (basic) | ¥162.77 | 2025-04-01 → 2026-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥28.35 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥9.51 | 2023-04-01 → 2024-03-31v | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥54.24 | 2022-04-01 → 2023-03-31v | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥67.08 | 2021-04-01 → 2022-03-31v | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥162.22 | 2025-04-01 → 2026-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥28.24 | 2024-04-01 → 2025-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥9.47 | 2023-04-01 → 2024-03-31v | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥54.09 | 2022-04-01 → 2023-03-31v | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥67.05 | 2021-04-01 → 2022-03-31v | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| Net assets per share | ¥1,020.96 | at 2026-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥845.25 | at 2025-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥890.07 | at 2024-03-31v | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥839.26 | at 2023-03-31v | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥799.26 | at 2022-03-31v | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Equity ratio | 51.3% | at 2026-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 45.3% | at 2025-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 44.7% | at 2024-03-31v | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 61.4% | at 2023-03-31v | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 62.6% | at 2022-03-31v | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| ROE | 17.4% | 2025-04-01 → 2026-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 3.3% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 1.1% | 2023-04-01 → 2024-03-31v | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 6.7% | 2022-04-01 → 2023-03-31v | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 8.7% | 2021-04-01 → 2022-03-31v | Cons. | Rate of return on equity IFRS (5-year summary) |
| Employees | 14,099 | at 2026-03-31 | Cons. | Number of employees |
| Employees | 13,643 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 14,754 | at 2024-03-31v | Cons. | Number of employees |
| Employees | 14,484 | at 2023-03-31v | Cons. | Number of employees |
| Employees | 14,522 | at 2022-03-31v | Cons. | Number of employees |
| Revenue | ¥888.1bn | 2025-04-01 → 2026-03-31 | Standalone | Net sales |
| Revenue | ¥789.6bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥688.4bn | 2023-04-01 → 2024-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥613.6bn | 2022-04-01 → 2023-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥542.6bn | 2021-04-01 → 2022-03-31v | Standalone | Net sales (5-year summary) |
| Operating income | ¥273.4bn | 2025-04-01 → 2026-03-31 | Standalone | Operating income |
| Operating income | ¥267.3bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Ordinary income | ¥513.1bn | 2025-04-01 → 2026-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥431.1bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥373.3bn | 2023-04-01 → 2024-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥338.2bn | 2022-04-01 → 2023-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥270.5bn | 2021-04-01 → 2022-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥434.1bn | 2025-04-01 → 2026-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥362.2bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Net income | ¥368.0bn | 2025-04-01 → 2026-03-31 | Standalone | Profit loss |
| Net income | ¥319.7bn | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥292.2bn | 2023-04-01 → 2024-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥314.2bn | 2022-04-01 → 2023-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥225.1bn | 2021-04-01 → 2022-03-31v | Standalone | Net income loss (5-year summary) |
| Total assets | ¥2.65T | at 2026-03-31 | Standalone | Assets |
| Total assets | ¥2.56T | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥2.46T | at 2024-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.49T | at 2023-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.39T | at 2022-03-31v | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥1.05T | at 2026-03-31 | Standalone | Liabilities |
| Total liabilities | ¥1.19T | at 2025-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.60T | at 2026-03-31 | Standalone | Net assets |
| Net assets / equity | ¥1.37T | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥1.18T | at 2024-03-31v | Standalone | Net assets |
| Net assets / equity | ¥1.02T | at 2023-03-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥873.6bn | at 2022-03-31v | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥110.1bn | at 2026-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥46.6bn | at 2025-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥205.47 | 2025-04-01 → 2026-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥178.59 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥162.92 | 2023-04-01 → 2024-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥172.64 | 2022-04-01 → 2023-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥121.69 | 2021-04-01 → 2022-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥205.43 | 2025-04-01 → 2026-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥178.55 | 2024-04-01 → 2025-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥162.87 | 2023-04-01 → 2024-03-31v | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥172.57 | 2022-04-01 → 2023-03-31v | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥121.63 | 2021-04-01 → 2022-03-31v | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥78 | 2025-04-01 → 2026-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥74 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥70 | 2023-04-01 → 2024-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥60 | 2022-04-01 → 2023-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥50 | 2021-04-01 → 2022-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥892.92 | at 2026-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥763.31 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥660 | at 2024-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥568.97 | at 2023-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥477.81 | at 2022-03-31v | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 60.4% | at 2026-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 53.4% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 48.1% | at 2024-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 68.7% | at 2023-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.9% | at 2022-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 24.8% | 2025-04-01 → 2026-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 25.1% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 26.5% | 2023-04-01 → 2024-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 33.2% | 2022-04-01 → 2023-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 27.1% | 2021-04-01 → 2022-03-31v | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 1,809,663,000 | at 2026-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,809,663,000 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,809,663,000 | at 2024-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,809,663,000 | at 2023-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,835,852,000 | at 2022-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Employees | 4,081 | at 2026-03-31 | Standalone | Number of employees |
| Employees | 4,105 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 4,806 | at 2024-03-31v | Standalone | Number of employees |
| Employees | 4,867 | at 2023-03-31v | Standalone | Number of employees |
| Employees | 3,943 | at 2022-03-31v | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 2
| Segment | Item | Period | Value |
|---|---|---|---|
| Pharmaceuticalreportable segment | employees | at 2026-03-31 | 14099 pure |
| Pharmaceuticalreportable segment | employees | at 2026-03-31 | 4081 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,728
| Item | Context | Value | Unit |
|---|---|---|---|
| Buildings and structures accumulated depreciation and impairment losses IFRS | CurrentYearInstant | -148200000000 | JPY |
| Machinery and vehicles accumulated depreciation and impairment losses IFRS | CurrentYearInstant | -117763000000 | JPY |
| Tools furniture and fixtures accumulated depreciation and impairment losses IFRS | CurrentYearInstant | -96248000000 | JPY |
| Land accumulated impairment losses IFRS | CurrentYearInstant | -309000000 | JPY |
| Construction in progress accumulated impairment losses IFRS | CurrentYearInstant | -72000000 | JPY |
| Right of use assets accumulated depreciation and impairment IFRS | CurrentYearInstant | -75025000000 | JPY |
| Property plant and equipment accumulated depreciation and impairment losses IFRS | CurrentYearInstant | -437617000000 | JPY |
| Buildings and structures IFRS | CurrentYearInstant | 143505000000 | JPY |
| Machinery and vehicles IFRS | CurrentYearInstant | 18175000000 | JPY |
| Tools furniture and fixtures IFRS | CurrentYearInstant | 34954000000 | JPY |
| Land IFRS | CurrentYearInstant | 17891000000 | JPY |
| Construction in progress IFRS | CurrentYearInstant | 67018000000 | JPY |
| Right of use assets IFRS | CurrentYearInstant | 76880000000 | JPY |
| Property plant and equipment IFRS | CurrentYearInstant | 358424000000 | JPY |
| Goodwill acquisition cost IFRS | Prior1YearInstant | 415207000000 | JPY |
| Goodwill accumulated impairment losses IFRS | Prior1YearInstant | － | JPY |
| Goodwill IFRS | Prior1YearInstant | 415207000000 | JPY |
| Goodwill acquisition cost IFRS | CurrentYearInstant | 441175000000 | JPY |
| Goodwill accumulated impairment losses IFRS | CurrentYearInstant | － | JPY |
| Goodwill IFRS | CurrentYearInstant | 441175000000 | JPY |
| Technology related to research and manufacturing acquisition cost IFRS | Prior1YearInstant | 214354000000 | JPY |
| In process research and development acquisition cost IFRS | Prior1YearInstant | 443861000000 | JPY |
| Marketing rights acquisition cost IFRS | Prior1YearInstant | 1198532000000 | JPY |
| Other components of intangible assets acquisition cost IFRS | Prior1YearInstant | 120160000000 | JPY |
| Intangible assets acquisition cost IFRS | Prior1YearInstant | 1976908000000 | JPY |
| Technology related to research and manufacturing accumulated amortization and impairment losses IFRS | Prior1YearInstant | -83743000000 | JPY |
| In process research and development accumulated amortization and impairment losses IFRS | Prior1YearInstant | -297177000000 | JPY |
| Marketing rights accumulated amortization and impairment losses IFRS | Prior1YearInstant | -392649000000 | JPY |
| Other components of intangible assets accumulated amortization and impairment losses IFRS | Prior1YearInstant | -79625000000 | JPY |
| Intangible assets accumulated amortization and impairment losses IFRS | Prior1YearInstant | -853194000000 | JPY |
| Technology related to research and manufacturing IFRS | Prior1YearInstant | 130611000000 | JPY |
| In process research and development IFRS | Prior1YearInstant | 146685000000 | JPY |
| Marketing rights IFRS | Prior1YearInstant | 805883000000 | JPY |
| Other components of intangible assets IFRS | Prior1YearInstant | 40535000000 | JPY |
| Intangible assets IFRS | Prior1YearInstant | 1123714000000 | JPY |
| Technology related to research and manufacturing acquisition cost IFRS | CurrentYearInstant | 183191000000 | JPY |
| In process research and development acquisition cost IFRS | CurrentYearInstant | 316239000000 | JPY |
| Marketing rights acquisition cost IFRS | CurrentYearInstant | 1410169000000 | JPY |
| Other components of intangible assets acquisition cost IFRS | CurrentYearInstant | 111901000000 | JPY |
| Intangible assets acquisition cost IFRS | CurrentYearInstant | 2021501000000 | JPY |
| Technology related to research and manufacturing accumulated amortization and impairment losses IFRS | CurrentYearInstant | -87861000000 | JPY |
| In process research and development accumulated amortization and impairment losses IFRS | CurrentYearInstant | -215551000000 | JPY |
| Marketing rights accumulated amortization and impairment losses IFRS | CurrentYearInstant | -627317000000 | JPY |
| Other components of intangible assets accumulated amortization and impairment losses IFRS | CurrentYearInstant | -93840000000 | JPY |
| Intangible assets accumulated amortization and impairment losses IFRS | CurrentYearInstant | -1024569000000 | JPY |
| Technology related to research and manufacturing IFRS | CurrentYearInstant | 95330000000 | JPY |
| In process research and development IFRS | CurrentYearInstant | 100688000000 | JPY |
| Marketing rights IFRS | CurrentYearInstant | 782852000000 | JPY |
| Other components of intangible assets IFRS | CurrentYearInstant | 18062000000 | JPY |
| Intangible assets IFRS | CurrentYearInstant | 996932000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 21 of 21 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |